2022
DOI: 10.2196/31237
|View full text |Cite
|
Sign up to set email alerts
|

The Use of HIV Pre- and Postexposure Prophylaxis Among a Web-Based Sample of HIV-Negative and Unknown Status Cisgender and Transgender Sexual Minority Men: Cross-sectional Study

Abstract: Background HIV disproportionately affects sexual minority men (SMM) in the United States. Objective We sought to determine past HIV postexposure prophylaxis (PEP) use and current and prior pre-exposure prophylaxis (PrEP) use among a web-based sample of cisgender and transgender men who have sex with men. Methods In 2019, HIV-negative and unknown status SMM (n=63,015) were recruited via geosocial networking a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 57 publications
(62 reference statements)
0
2
0
Order By: Relevance
“…Even when participants had initial negative reactions to LAI-PrEP, these negative perceptions were frequently considered in conjunction with its unique strengths, indicating acceptability of LAI-PrEP is very individualized and potentially amenable to decision aid intervention strategies. Importantly, we found LAI-PrEP to be appealing for all individuals, including specific subpopulations of YSMM with lower uptake of oral PrEP—such as Black, Latino, and transgender YSMM 49 —indicating the potential for LAI-PrEP to be considered among YSMM who are not currently taking oral PrEP.…”
Section: Discussionmentioning
confidence: 85%
“…Even when participants had initial negative reactions to LAI-PrEP, these negative perceptions were frequently considered in conjunction with its unique strengths, indicating acceptability of LAI-PrEP is very individualized and potentially amenable to decision aid intervention strategies. Importantly, we found LAI-PrEP to be appealing for all individuals, including specific subpopulations of YSMM with lower uptake of oral PrEP—such as Black, Latino, and transgender YSMM 49 —indicating the potential for LAI-PrEP to be considered among YSMM who are not currently taking oral PrEP.…”
Section: Discussionmentioning
confidence: 85%
“…Since receiving Food and Drug Administration approval in 2012, the modes of PrEP for HIV prevention include dosing options such as once-daily oral pills, on-demand oral pills, or a long-acting injectable every 8 weeks [ 22 ]. Nonetheless, PrEP uptake among young sexual minoritized men has been suboptimal, with fewer than 17% of young sexual minoritized men reporting PrEP use in 2019 [ 23 ] despite research indicating nearly 44% of young sexual minoritized men could benefit from PrEP based on federal guidelines [ 21 - 23 ].…”
Section: Introductionmentioning
confidence: 99%